Publications by authors named "Jordan C Pruce"

Claim this Profile
C
Clinical and Endoscopic Outcomes Through 78 Weeks of Tofacitinib Therapy for Ulcerative Colitis in a US Cohort.
Rahul S Dalal, Puza P Sharma, Kanwal Bains, Jordan C Pruce, Jessica R Allegretti

Inflamm Bowel Dis· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
1-Year Comparison of Clinical and Endoscopic Outcomes of Tofacitinib vs Vedolizumab for Ulcerative Colitis After Anti-Tumor Necrosis Factor Failure: A Real-World Cohort Study in the United States.
Rahul S Dalal, Puza P Sharma, Kanwal Bains, Jordan C Pruce, Jessica R Allegretti

Inflamm Bowel Dis· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
1-Year Comparative Effectiveness of Tofacitinib vs Ustekinumab for Patients With Ulcerative Colitis and Prior Antitumor Necrosis Factor Failure.
Rahul S Dalal, Puza P Sharma, Kanwal Bains, Jordan C Pruce, Jessica R Allegretti

Inflamm Bowel Dis· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Outcomes After Ustekinumab Dose Intensification for Inflammatory Bowel Diseases.
Rahul S Dalal, Jordan C Pruce, Jessica R Allegretti

Inflamm Bowel Dis· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors and Outcomes of Ustekinumab Dose Intensification in Ulcerative Colitis: A Multicenter Cohort Study.
Rahul S Dalal, Scott Esckilsen, Edward L Barnes, Jordan C Pruce, Jenna Marcus

Clin Gastroenterol Hepatol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis